What is the impact of a Hepatitis C 'test, trace and treat' pilot using peer workers?

Chronic Hepatitis C virus (HCV) infection is a major cause of morbidity and deaths worldwide. HCV treating teams are working toward the goal of eliminating HCV by 2030. People who inject drugs (PWIDs) are at high risk of HCV but contact tracing is not routine practice. Here, we present the outcomes...

Full description

Saved in:
Bibliographic Details
Published in:Journal of viral hepatitis 2023-12, Vol.30 (12), p.922-925
Main Authors: Caroline, Allsop, Kate, Mcque, Roberts, Mark, Ryan, Jelley, Murphy, Suzanne, Richardson, Carrie, Coyte, Aishah, Taha, Yusri, Stuart, McPherson
Format: Article
Language:English
Subjects:
Antiviral agents
Antiviral Agents - therapeutic use
Chronic infection
Contact tracing
Hepacivirus - genetics
Hepatitis C
Hepatitis C - diagnosis
Hepatitis C - drug therapy
Hepatitis C, Chronic - diagnosis
Hepatitis C, Chronic - drug therapy
Humans
Morbidity
Reinfection
RNA
Substance Abuse, Intravenous - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic Hepatitis C virus (HCV) infection is a major cause of morbidity and deaths worldwide. HCV treating teams are working toward the goal of eliminating HCV by 2030. People who inject drugs (PWIDs) are at high risk of HCV but contact tracing is not routine practice. Here, we present the outcomes of a HCV 'test, trace and treat' pilot using peer workers to test contacts of individuals with HCV. PWIDs with HCV were invited to participate when they presented for treatment. For those agreeing to participate, a peer approached them to invite potential contacts for HCV testing. Data were collected on uptake, HCV test results, treatment rates and reasons for declining. Overall, 295 individuals (162 recent HCV [
ISSN:1352-0504
1365-2893
DOI:10.1111/jvh.13888